Review in Frontiers in Physiology
The Fukuda 1994 definition of CFS ‘nets’ a wide range of patients, yet it remains the most widely recognised definition,…
Lessons from the XMRV fiasco
Between 2009 and 2012, the controversy over the retroviruses XMRV/XMLV and their role in ME/CFS involved a tumultuous roller-coaster ride…
Personality disorders not a factor
CDSM-IV axis II personality disorders involve ‘maladaptive personality traits’, such as obsessive–compulsive disorder. A study from Belgium reports no increase…
Review of cognitive symptoms
A fine review of the cognitive problems associated with ME/CFS, and the subgroup of patients with postural tachycardia syndrome (POTS),…
Treatment outcomes
More than 8,000 adults are assessed and treated by specialist NHS ‘CFS/ME’ clinical teams every year in the UK, but…
An Interview With Prof Julia Newton
In a very interesting interview with ProHealth.com, Prof Newton shares some insights into the UK’s ME/CFS Research Collaborative, aspects of…
Spotlight on Definitions
There are a number of possible definitions of ME and CFS but each is different, and the terms ME, CFS…
ME/CFS and the risk of cancer
The fact that ME/CFS has an infectious onset in many cases, and is associated with abnormalities of cellular immunity, raises…
Slowing of information processing
Neurocognitive problems are one of the most frequent and disabling symptoms associated with ME/CFS. In fact, around 90% of 2073…
Is ME/CFS different in elderly people?
We know that around 200,000 are living with ME/CFS at any one time in the UK, and that most become…
